Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV – the role of epoetin, G‐CSF and novel agents

R. MAC NICHOLAS, S. NORRIS

Open source

DOI
10.1111/j.1365-2036.2010.04269.x
Published
2010-04-05
Container
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/j.1365-2036.2010.04269.x,
  title = {Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV – the role of epoetin, G‐CSF and novel agents},
  author = {R. MAC NICHOLAS and S. NORRIS},
  year = {2010},
  journal = {Alimentary Pharmacology \& Therapeutics},
  doi = {10.1111/j.1365-2036.2010.04269.x},
  url = {https://doi.org/10.1111/j.1365-2036.2010.04269.x}
}

RIS

TY  - JOUR
TI  - Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV – the role of epoetin, G‐CSF and novel agents
AU  - R. MAC NICHOLAS
AU  - S. NORRIS
PY  - 2010
JO  - Alimentary Pharmacology & Therapeutics
DO  - 10.1111/j.1365-2036.2010.04269.x
UR  - https://doi.org/10.1111/j.1365-2036.2010.04269.x
ER  - 

APA

NICHOLAS, R. M., & NORRIS, S. (2010). Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV – the role of epoetin, G‐CSF and novel agents. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2010.04269.x

Source records